cefazolin + cephalexin + clindamycin

This is a combination of three antibiotics—cefazolin, cephalexin, and clindamycin—each with distinct but complementary antibacterial spectra. - **Cefazolin** is a first-generation cephalosporin antibiotic administered parenterally, primarily used for moderate to severe bacterial infections including those of the skin, bone, joint, lung, stomach, blood, heart valve, and urinary tract. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and death[1][7][9]. - **Cephalexin** is also a first-generation cephalosporin but administered orally. It treats infections caused by susceptible gram-positive bacteria such as skin or soft tissue infections and bone infections. Its mechanism mirrors that of cefazolin—inhibition of bacterial cell wall synthesis via PBPs[1][3]. - **Clindamycin** is a lincosamide antibiotic effective against anaerobic bacteria and certain gram-positive cocci (including staphylococci and streptococci). It inhibits protein synthesis by binding to the 50S ribosomal subunit in bacteria[5][6]. Clindamycin is often reserved for serious or anaerobic infections or when patients are allergic to beta-lactams. The combination may be considered in complex polymicrobial infections where broad coverage—including both aerobic gram-positive organisms (via cefazolin/cephalexin) and anaerobes (via clindamycin)—is desired.